NFKB1 and atherosclerosis: To conclude, these studies demonstrate the therapeutic benefits of phenolic metabolites in reducing inflammation and atherosclerosis development and suggests that targeting the NF-κB could be a promising approach for the prevention and treatment of vascular function.